
Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …

The new blockbuster hepatitis C treatments Sovaldi and Harvoni more than doubled Gilead’s sales in the last quarter of 2014 …
Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

